Author: Ali Shadan El-Rayes Basil Aranha Olivia Sarkar Fazlul Philip Philip
Publisher: Springer Publishing Company
ISSN: 0167-6806
Source: Breast Cancer Research and Treatment, Vol.90, Iss.1, 2005-03, pp. : 25-31
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Sorafenib combined with gemcitabine in EGFRTKIresistant human lung cancer cells
Oncology Letters, Vol. 5, Iss. 1, 2013-01 ,pp. :